Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200602047638N1
IRCT20200602047638N1
Not yet recruiting
未知

Design and assessment of a preventive behavioral training program for Sexual Transmited Infections among women

Faculty of Medical Sciences, Tarbiat Modares University0 sites150 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionssexually transmitted infections (STIs).Early congenital syphilis, symptomatic-Early syphilisA50.0-A51.

Overview

Phase
未知
Intervention
Not specified
Conditions
sexually transmitted infections (STIs).
Sponsor
Faculty of Medical Sciences, Tarbiat Modares University
Enrollment
150
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Faculty of Medical Sciences, Tarbiat Modares University

Eligibility Criteria

Inclusion Criteria

  • •Living in Tehran
  • •without any chronic debilitating diseases such as (cancer, MS, acute heart disease)
  • •age 18 to 48 years
  • •having a minimum literacy and ability to answer questions and discuss in training classes

Exclusion Criteria

  • •Mental disorders
  • •drug dependence and addiction

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
The development and evaluation of a behavioural program to treat drooling in children wit Cerebral Palsycerebral palsy10014623
NL-OMON30394Sint Maartenskliniek20
Completed
Not Applicable
Development and validation of preventive physical therapy using health literacy education for care preventioCommunity-dwelling older adults
JPRN-UMIN000038310Toyama Prefectural University141
Completed
Not Applicable
Interventional study to optimize the preventive behavior in first-degree relatives of patients with colorectal carcinomaColorectal carcinoma (CRC) prevention, the preventive behavior in first-degree relativesC26.0Intestinal tract, part unspecified
DRKS00006818Medizinische Klinik II,Onkologie / Hämatologie und Sektion Pneumologie,Hubertus Wald Tumorzentrum,Universitäres Cancer Center (UCCH),Universitätsklinikum Eppendorf215
Active, not recruiting
Phase 1
BOOM study (Benzydamine Oromucosal solution in Oral Mucositis)
EUCTR2020-003306-32-PLAngelini Pharma S.p.A.100
Active, not recruiting
Phase 1
BOOM study (Benzydamine Oromucosal solution in Oral Mucositis)Oral Mucositis (OM) in patients with head and neck cancer (HNC)MedDRA version: 20.0Level: LLTClassification code 10056468Term: Oral mucosal disorderSystem Organ Class: 100000004856Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2020-003306-32-HUAngelini Pharma S.p.A.100